Skip to main content
Signal8

Kariuki Enoch

SEC insider (Form 3/4/5 filer). CIK 0001843119. Director at Zentalis Pharmaceuticals, Inc. (ZNTL). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 16, 2026. Located in SAN DIEGO, CA.

Companies Kariuki Enoch has filed insider reports for

  • Zentalis Pharmaceuticals, Inc. (ZNTL): Director
Kariuki Enoch profile photo

Kariuki Enoch

CIK: 0001843119

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Zentalis Pharmaceuticals, Inc. logo
ZNTL

Zentalis Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Zentalis Pharmaceuticals, Inc. logo
    ZNTL

    Zentalis Pharmaceuticals, Inc.

    Jun 16, 2026
    Award
    Direct
    57.1K shares-
  • Zentalis Pharmaceuticals, Inc. logo
    ZNTL

    Zentalis Pharmaceuticals, Inc.

    Jun 17, 2025
    Award
    Direct
    57.6K shares-

1-2 of 2